Skip to main content
. 2022 Jul 25;4(4):dlac080. doi: 10.1093/jacamr/dlac080

Table 2.

Crude patient-related outcomes (mortality, length of stay and recovered renal function at 30 days) at 30 days dependent on renal function on admission

Normal renal function AKI stage 1 AKI stage ≥2 CKD 4/5
Unadjusted 30 day in-hospital mortality, n/N (%) 25/352 (7.1) 14/112 (12.5) 26/123 (21.1) 11/60 (18.3)
Length of stay, days, median (range) 5.7 (0–307) 10.8 (0–195) 12.8 (1–122) 7.3 (0–78)
Recovery of renal function (at discharge or 21 days), n/N 100/101 96/97